New Key Statistics Module, Z-Score and F-Score
OTCPK:CRRTF Key Ratios
| Market Cap $ M | 7.27 |
| Enterprise Value $ M | 1.12 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.55 |
| Price/Sales | 0.57 |
| Price/Free Cash Flow | 31.88 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 13.00 |
| EPS (TTM) $ | -0.08 |
| Beneish M-Score | -3.23 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -47.70 |
| y-y EBITDA Growth Rate % | -108.10 |
| EV-to-EBIT | -0.78 |
| EV-to-EBITDA | -7.22 |
| PEG | -- |
| Shares Outstanding M | 19.44 |
| Net Margin (%) | -13.06 |
| Operating Margin % | -13.68 |
| Pre-tax Margin (%) | -11.44 |
| Quick Ratio | 2.60 |
| Current Ratio | 3.59 |
| ROA % (ttm) | -9.11 |
| ROE % (ttm) | -11.99 |
| ROIC % (ttm) | -24.15 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.38 |
CRRTF Number of Guru Trades
CRRTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CRRTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CRRTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Crescita Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:CRRTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers